Results 1 to 10 of about 22,249,811 (294)
Colorectal cancer is the third most common cancer worldwide and the second cause of death from malignant tumors. Colorectal cancers are treated with surgery, chemotherapy, gene therapy and immunotherapy.
Paulina Poter +5 more
doaj +2 more sources
Triterpene acid and phenolic constituents from nine ancient varieties of apple (Malus domestica) fruits cultivated in Fanna, Friuli Venezia Giulia region, northeast Italy, were analyzed and compared with four commercial apples (‘Golden Delicious ...
Stefania Sut +4 more
doaj +1 more source
Background and Aims Anti‐PD‐1/PD‐L1 immunotherapy has changed the treatment landscape of lung cancer. This new approach provides the ability to revitalize the immune system to specifically target and kill cancer cells, thereby creating a new treatment ...
Md Mohiuddin
doaj +1 more source
Latar Belakang: Diabetes menjadi penyakit yang semakin umum terjadi. Diabetes melitus tipe 2 merupakan penyakit metabolik kronis yang dapat menyebabkan kerusakan pankreas dan gangguan fungsi ginjal.
Amelia Luthfiyah Mulyadewi +2 more
doaj +1 more source
FBXO38 is dispensable for PD-1 regulation
Abstract SKP1-CUL1-F-box protein (SCF) ubiquitin ligases are versatile protein complexes that mediate the ubiquitination of protein substrates. The direct substrate recognition relies on a large family of F-box-domain-containing subunits. One of these substrate receptors is FBXO38, which is encoded by a gene found
Nikol Dibus +6 more
openaire +3 more sources
STK25 Loss Augments Anti‐PD‐1 Therapy Efficacy by Regulating PD‐L1 Stability in Colorectal Cancer
Tumor immune evasion is intricately linked to malignant tumor progression and contributes to the failure of anti‐cancer immunotherapy. Serine/threonine protein kinase 25 (STK25) has been previously implicated in the progression of various neoplastic ...
Xiaowen Qiao +20 more
doaj +1 more source
Meta-analysis of the correlation between glioma prognosis and PD-1/PD-L1 expression
Chang-cheng Ren +6 more
doaj +1 more source
Protein programirane celične smrti 1:PD-1 (Programmed cell death protein 1) je transmembranski protein, ki je izražen na celicah T, B, NK ter monocitih in dendritičnih celicah.
Janja Ocvirk
doaj
Characterization of Anti-Canine PD-1 Antibodies. [PDF]
Hartman CJ +16 more
europepmc +1 more source

